Hemophilia & Coagulation Program (Pediatric)

Hemophilia & Coagulation Program (Pediatric)

  • About
  • Approach
  • Appointments
  • Locations
  • Doctors

    • The University of Michigan Health Pediatric Hemophilia and Coagulation Disorders Program is the beginning of a lifetime of care. We are a member of a network of federally funded Hemophilia Treatment Centers. Our patients include infants, children, adolescents, and young adults, who are then transitioned to our adult program.

    Our Approach

    We are renowned for our expertise in the treatment of hemophilia, bleeding disorders and thrombosis (inappropriate or excessive blood clotting). Our physicians are members of local, national, and international organizations dedicated to the care of these disorders, with many clinical trials open at this center. They also perform research in a variety of areas, including novel gene therapeutic approaches for the treatment of hemophilia and studies of the complex genetics of bleeding and clotting disorders.

    Appointment Information

    For more information regarding the program, or to schedule an appointment, please call 734-936-9814 or email [email protected].

    Locations
    • Hemophilia & Coagulation Disorders Clinic | C. S. Mott Children's Hospital 1540 E Hospital Dr
      Floor 7 Reception C
      Ann Arbor, MI 48109-4257       Get Directions
    • Pediatric Hematology Clinic | C. S. Mott Children's Hospital 1540 E Hospital Dr
      Floor 7 Reception C
      Ann Arbor, MI 48109-4257       Get Directions

    Doctors

     Search for a U-M Health doctor     Mary McGrath, MD

    Mary McGrath, MD

    Clinical Assistant Professor

    Pediatric Hematology-Oncology, Pediatrics

    Steven Wesley Pipe, MD

    Steven Wesley Pipe, MD

    Professor

    Pediatric Hematology-Oncology, Pediatrics

    Jordan Adam Shavit, MD, PhD

    Professor

    Pediatric Hematology-Oncology, Pediatrics

    Jillian Simoneau, MD

    Jillian Simoneau, MD

    Clinical Instructor

    Pediatric Hematology-Oncology, Pediatrics

    Angela Christine Weyand, MD

    Angela Christine Weyand, MD

    Clinical Associate Professor

    Pediatric Hematology-Oncology, Pediatrics

    News & Stories
    little boy with basketballs and Michigan C.S. Mott logo behind him
    Health Lab

    First U-M patient receives newly FDA-approved stem cell therapy for sickle cell anemia

    Elijah Dottery, diagnosed with sickle cell anemia as a baby, becomes the first U-M patient to receive the newly-approved FDA therapy which involves using mesenchymal stem cells.
         Cancer Aware surrounded by a circle of multicolor ribbons
    Cancer Aware

    CAR T-cell Therapy

    Using one's cells to attack and treat cancer continues to grow. Cellular therapy and in particular CAR T-cell therapy offers new opportunities to adult and pediatric patients with blood cancers like leukemia and lymphoma. Dr. Monalisa Ghosh, Rogel Cancer Center oncologist talks about these treatments and and the future of cellular therapy.
    Health Lab

    Two Big Ten schools connected by one bone marrow donation

    The National Marrow Donor Program matches bone marrow donors with those who need it for cancer or blood disorder treatment. A University of Michigan Medical School graduate was able to give her marrow and a second chance at life to a young girl in Nebraska.
         PURPLE BLUE RED CELLS FLOATING
    Health Lab

    Using cellular therapy to treat cancer, and beyond

    Here, Monalisa Ghosh, M.D., a hematologist-oncologist at the University of Michigan Health Rogel Cancer Center, answers questions about cellular therapy; how it's used and what exciting developments are soon to come.
         blood cells floating red maroon
    Health Lab

    Most babies with sickle cell disease face double disadvantage

    Babies born with sickle cell disease face social inequality as well as a lifelong chronic disease that is often undertreated with proven drugs.
         sickle cell gene therapy pink
    Health Lab

    Gene therapy to treat sickle cell disease

    How two newly approved gene therapies, including novel technology CRISPR, may help kids and adults with inherited blood disorders